Urinary biomarkers of prenatal atrazine exposure and adverse birth outcomes in the PELAGIE birth cohort. by Chevrier, Cécile et al.
Urinary biomarkers of prenatal atrazine exposure and
adverse birth outcomes in the PELAGIE birth cohort.
Ce´cile Chevrier, Gwendolina Limon, Christine Monfort, Florence Rouget,
Ronan Garlante´zec, Claire Petit, Gae¨l Durand, Sylvaine Cordier
To cite this version:
Ce´cile Chevrier, Gwendolina Limon, Christine Monfort, Florence Rouget, Ronan Garlante´zec,
et al.. Urinary biomarkers of prenatal atrazine exposure and adverse birth outcomes in the
PELAGIE birth cohort.. Environmental Health Perspectives, National Institute of Environ-
mental Health Sciences, 2011, 119 (7), pp.1034-41. <10.1289/ehp.1002775>. <hal-00682592>
HAL Id: hal-00682592
https://hal.archives-ouvertes.fr/hal-00682592
Submitted on 23 Oct 2013
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
1034 volume 119 | number 7 | July 2011 • Environmental Health Perspectives
Research | Children’s Health
Atrazine is a triazine herbicide used to control 
broadleaf and grassy weeds in crops, mainly 
corn and sorghum. Although the European 
Union banned atrazine in 2001 because it 
is a ubiquitous water contaminant, it is still 
used in > 70 countries, including the United 
States, Brazil, Argentina, Mexico, and China 
(LeBaron et al. 2008). In 2001, agricultural 
pesticide use in France was among the highest 
in Europe, averaging 3.4 kg/hectare of agri-
cultural area (Benoît et al. 2005). The inten-
sive regional agricultural activities from pig, 
poultry, and dairy farming in the Brittany 
region (northwestern France) make pesticide 
exposure a critical issue. Corn crops, espe-
cially animal feed corn, are common there. In 
2001, experts estimated that 200 tons of atra-
zine was applied to 70% of the corn grown 
in Brittany, for an average of 0.620 kg of 
atrazine per hectare (Agreste Bretagne 2001). 
In 1997, the Ministry of Agriculture limited 
atrazine to 1 kg/ha/year; in 2002, it banned 
the sale of numerous products containing 
atrazine and, in October 2003, finally banned 
atrazine use. The primary replacements have 
been alachlor and acetochlor, both chloroac-
etanilide herbicides.
Once released into the environment, 
atrazine is transformed over time by various 
chemical, photochemical, and biologically 
mediated reactions into other compounds, 
called degradates or metabolites. Water con-
tamination by atrazine and its degradates, 
including hydroxyatrazine and desethylatra-
zine, has decreased in Brittany since 2003, 
but many surveys still show environmental 
contamination in the region. Testing indi-
cates that 27% of water samples from Breton 
rivers had atrazine levels > 0.1 µg/L in 2003 
compared with 10% of samples in 2004, and 
only 1% in 2007, whereas atrazine degradates 
were detected in 76% of water samples in 
2003 and 20% in 2007 [Réseau CORPEP 
(Cellule d’Orientation Régionale pour la 
Protection des Eaux contre les Pesticides) 
2008]. Atrazine residues were also detected 
in surface and underground sources of human 
drinking water (Marchand 2006). In 2006 the 
maximum measured surface water concentra-
tion was 0.38 µg/L for atrazine and 0.37 µg/L 
for hydroxyatrazine, and underground lev-
els, 0.14 µg/L for atrazine, 0.38 µg/L for 
hydroxyatrazine, and 0.32 µg/L for desethyl-
atrazine. Finally, in drinking water of Brittany 
in 2005, when the regulatory limits of pesti-
cides (0.1 µg/L) were exceeded, it was mainly 
due to desethylatrazine (67%) and atrazine 
(17%) residues (Marchand 2006).
Some epidemiologic studies have looked 
at the potential impact of prenatal expo-
sure to atrazine or its environmental degra-
dates on pregnancy outcomes in the general 
population. Munger et al. (1997) collected 
data from 1984 through 1990 and observed 
higher rates of babies born small for gesta-
tional age (SGA) in Iowa (USA) communities 
with higher atrazine levels in their drinking 
water. In Brittany, Villanueva et al. (2005) 
found that the risk of SGA increased with the 
number of months of the third trimester of 
pregnancy occurring from May to September, 
months with the highest atrazine levels in 
drinking water there from 1990 through 
1998. Ochoa-Acuña et al. (2009) found a 
statistically significant increase in SGA prev-
alence associated with atrazine in drinking 
water in Indiana (USA) from 1993 through 
2007. In Washington State (USA), Waller 
et al. (2010) observed a higher risk of gas-
troschisis from 2001 through 2006 among 
babies of mothers who lived closer to sites 
with high atrazine concentrations. Three 
other studies related high incidences of birth 
defects to counties with high triazine use in 
New York (USA) from 1995 through 1999 
(Davis 2005), to the highest mean atrazine 
levels in surface water in Indiana from 1990 
through 2002 (Mattix et al. 2007), and to the 
annual April–July peak of atrazine contami-
nation of surface water [based on 1996–2002 
U.S. data (Winchester et al. 2009)]. Most of 
these studies were retrospective and relied on 
ecological exposure assessment. Co-occurring 
chemicals make it impossible to determine 
whether associations are specific to atrazine 
exposure in the general population.
Our aim was to assess the association 
between adverse birth outcomes and uri-
nary biomarkers of prenatal atrazine expo-
sure, taking into account other herbicides 
potentially used on corn, including simazine, 
alachlor, metolachlor, and acetochlor. This 
study is based on a prospective population-
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Background: Despite evidence of atrazine toxicity in developing organisms from experimental 
studies, few studies—and fewer epidemiologic investigations—have examined the potential effects 
of prenatal exposure.
oBjectives: We assessed the association between adverse birth outcomes and urinary biomarkers 
of prenatal atrazine exposure, while taking into account exposures to other herbicides used on corn 
crops (simazine, alachlor, metolachlor, and acetochlor).
Methods: This study used a case‑cohort design nested in a prospective birth cohort conducted in 
the Brittany region of France from 2002 through 2006. We collected maternal urine samples to 
examine pesticide exposure biomarkers before the 19th week of gestation.
results: We found quantifiable levels of atrazine or atrazine mercapturate in urine samples from 
5.5% of 579 pregnant women, and dealkylated and identified hydroxylated triazine metabolites in 
20% and 40% of samples, respectively. The presence versus absence of quantifiable levels of  atrazine 
or a specific atrazine metabolite was associated with fetal growth restriction [odds ratio (OR) = 1.5; 
95% confidence interval (CI), 1.0–2.2] and small head circumference for sex and gestational age 
(OR = 1.7; 95% CI, 1.0–2.7). Associations with major congenital anomalies were not evident with 
atrazine or its specific metabolites. Head circumference was inversely associated with the presence of 
quantifiable urinary metolachlor.
conclusions: This study is the first to assess associations of birth outcomes with multiple urinary 
biomarkers of exposure to triazine and chloroacetanilide herbicides. Evidence of associations with 
adverse birth outcomes raises particular concerns for countries where atrazine is still in use.
key words: atrazine, environmental exposure, fetal growth, herbicides. Environ Health Perspect 
119:1034–1041 (2011). doi:10.1289/ehp.1002775 [Online 2 March 2011]
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based cohort in the Brittany region—the 
PELAGIE (Perturbateurs endocriniens: 
Étude Longitudinale sur les Anomalies de la 
Grossesse, l’Infertilité et l’Enfance) cohort—
that collected urine samples from pregnant 
women between 2002 and 2006 to assess pes-
ticide exposure biomarkers before the 19th 
week of gestation.
Materials and Methods
The PELAGIE cohort. The PELAGIE cohort 
included 3,421 pregnant women from 
Brittany from 2002 through February 2006. 
Enrollment started in the district of Ille-et-
Vilaine, continued in Finistère, and ended in 
Côtes d’Armor. Gynecologists, obstetricians, 
and ultrasonographers recruited women during 
consultations in early pregnancy, informing 
them about the nature of the study and asking 
them to participate (after providing written 
consent). Women were enrolled before the 
19th week of gestation after providing written 
informed consent and completing a question-
naire at home concerning family social and 
demographic characteristics, diet, and lifestyle. 
Women were asked to return the questionnaire 
by mail, along with a first-morning-void urine 
sample that they collected and transferred into 
two vials containing nitric acid (to inhibit bac-
terial proliferation). Samples were mailed to 
the study laboratory (INSERM U625, Rennes, 
France) in a prestamped package at ambi-
ent temperature, with routine delivery taking 
from 1 to 3 days. On receipt, samples were 
frozen and stored at –20°C. Midwives and 
pediatricians at the maternity units provided 
study staff with medical information about 
the pregnancy, delivery, and neonatal health 
for 3,399 women (99.4% of the cohort; the 
other 22 women were lost to follow-up). Birth 
weight, length, and head circumference were 
obtained from hospital records by pediatri-
cians. Gestational age was based on both date 
of the last menstrual period and ultrasound 
examinations. The appropriate national ethics 
committees approved the study.
Outcome definition. Live-born singleton 
children of the cohort without major congen-
ital anomalies were classified as fetal growth 
restricted (FGR) if their birth weight was 
below the 5th percentile of the distribution 
of expected birth weight modeled within the 
cohort according to gestational age (third-
degree polynomial), sex, parity (third-degree 
polynomial), maternal weight (third-degree 
polynomial), height, and age (second-degree 
polynomial) (Mamelle et al. 2001). Small 
head circumference (SHC) was defined by a 
head circumference below the 5th percentile 
of the birth head circumference distribution 
for a given gestational age and sex, according 
to French reference curves (Mamelle et al. 
1996). Major congenital malformations in 
live-born infants were diagnosed by hospital 
staff pediatricians at the maternity unit, based 
on findings at the clinical examination at 
birth. In addition, pediatricians were asked 
specifically about male genital anomalies 
(hypospadias, undescended testis, and micro-
penis). Diagnosis validation by pediatric 
surgeons was obtained for half of these male 
genital anomalies (n = 12 of 26) up to 2 years 
after birth. For detailed information on the 
classification of congenital malformations in 
this cohort, see Garlantézec et al. (2009).
Data on corn agricultural activities and 
atrazine water contamination. Data on agri-
cultural activities were collected for each 
mother’s municipality of residence at enroll-
ment from the national agricultural census 
conducted in 2000; specifically, we recorded 
the proportion of the municipality’s area used 
for corn crops. Drinking water contamina-
tion by atrazine was routinely assessed until 
its year of ban by the office of Social and 
Sanitary Affairs of Brittany (Rennes, France). 
We collected these data from 2000 to 2002 
for municipalities in Ille-et-Vilaine and used 
them to estimate the average atrazine level in 
water during the first trimester of pregnancy 
for participants residing in these locations. 
Exposure to atrazine via tap water was then 
estimated by multiplying the average con-
centrations by the tap water consumption 
reported in the questionnaire.
Case-cohort design. The present study was 
based on a case-cohort design (Kass and Gold 
2004) that included 601 children randomly 
selected from the entire live-born singleton 
cohort (18%), referred to as the subcohort, 
and groups with adverse birth outcomes, 
including congenital anomalies (88 major 
anomalies, 26 male genital anomalies), FGR 
(n = 180), and SHC (n = 105), representing all 
of the cohort members with these outcomes.
Pesticide determination in urine samples. 
Pesticides were measured in urine samples 
from 579 women in the subcohort (96%), all 
mothers of babies with major congenital anom-
alies or male genital anomalies, 178 moth-
ers of children with FGR, and 103 mothers 
with children with SHC. First-morning-void 
urine samples, which are very likely to contain 
recent traces of exposure to the nonpersistent 
pesticides we targeted (Barr et al. 2005), were 
used to determine the presence of 12 triaz-
ine compounds: atrazine and its glutathione-
derived metabolite atrazine mercapturate, 
simazine and its metabolite simazine mercap-
turate, three dealkylated triazine metabolites 
that are likely to be formed in water systems 
(desethylatrazine, desisopropyl atrazine, and 
2-chlorodiaminoatrazine), and five hydroxy-
lated triazine metabolites, mostly formed in 
plants [hydroxyatrazine, hydroxysimazine, 
hydroxydesethylatrazine, hydroxy-desisopropyl 
atrazine, and hydroxy-2-chlorodiaminoatrazine 
(ammeline)]. The chloroacetanilide herbicides 
alachlor, metolachlor, and acetolachlor were 
also measured, together with 2,6-diethylani-
line, an alachlor metabolite.
Chemical analyses were performed by the 
Idhesa Institute (Plouzané, France) on urine 
samples (maximum, 10 mL) with liquid chro-
matography/triple-quadrupole mass spectrom-
etry (LC/MS-MS) after solid-phase extraction 
(SPE). Triazine and chloroacetanilide herbi-
cides were analyzed simultaneously. Reference 
standards for pesticides and their metabo-
lites were purchased from the Ehrenstörfer 
laboratory (Augsburg, Germany) and from 
Promochem (Teddington, UK). Other pur-
chased chemicals included LC/MS-grade ace-
tonitrile and methanol from Fisher Scientific 
(> 99%; Loughborough, Leicestershire, UK), 
analytical-grade formic acid from Baker 
(98%; Deventer, Netherlands), and gas from 
Air Liquide (> 99%; Paris, France). Standard 
solutions were prepared in methanol or ace-
tonitrile and stored at –20°C. Simazine-d10 
was used as internal standard for extraction 
and detection controls. Calibration standards 
were prepared by adding appropriate working 
standard solutions to 10-mL fresh samples of 
pesticide-free human urine before extraction to 
obtain concentrations in the calibration range. 
Isotope-labeled standards and surrogates were 
added to calibration standards to obtain a final 
concentration of 1 µg/L. The urine samples 
were thawed and shaken. Preconcentration 
and extraction (5 mL) were performed with 
an online SPE high-volume symbiosis sys-
tem (Spark Holland, Emmen, Netherlands)
and the Hysphere C18 HD cartridge (2 × 
10 mm; Spark Holland), and analytes were 
eluted during the mobile phase. Separation 
was performed with Synergy fusion-RP ana-
lytical column (250 mm × 2.0 mm, 4 µm par-
ticle diameter; Phenomenex, Torrance, CA, 
USA) preceded by a guard column (4 mm 
× 2 mm) of the same packing material from 
Phenomenex. The mobile phase was a gradient 
of a mixture of 5 mm ammonium formate/
formic acid 0.01% and acetonitrile/formic 
acid 0.01%. The flow rate was 0.2 mL/min, 
and the temperature 35°C. LC/MS-MS analy-
ses were performed with a system composed 
of a Waters alliance 2690 LC pump equipped 
with an autosampler and connected in series 
with a Quattro Ultima triple-quadrupole mass 
spectrometer (Waters-Micromass, Manchester, 
UK), equipped for electrospray ionization. 
Acquisition took place in multiple-reaction 
monitoring mode, with two transitions per 
compound (one for quantification and one 
for confirmation) in positive ionization mode. 
All validation procedures were performed with 
fresh samples of herbicide-free human urine. 
The limit of detection (LOD) was defined as 
a signal three times the background noise at 
the lowest analyte concentration assayed, and 
the limit of quantification (LOQ) as 10 times 
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the background noise. LOQs ranged from 
0.001 to 1.7 µg/L. Concentration ranges were 
linear from 0.010 to 10 µg/L for herbicides 
with the lowest LODs (metolachlor, desethyl-
atrazine, alachlor, 2,6-diethylaniline) and were 
linear from the LOD for the others. Average 
recoveries were 100% ± 20%, with coefficients 
of variation ranging from 0.1% to 13.9%. 
Stability tests showed, among doped human 
urinary samples, a slight decrease in levels after 
32 hr at ambient temperatures (respectively, 
–7% and –9% for atrazine and atrazine mer-
capturate) and no changes according to the 
presence of nitric acid. This method is reported 
to provide minimal sample handling, good 
extraction recovery, and satisfactory LODs 
and LOQs (Panuwet et al. 2008, 2010).
Definition of exposure profiles from uri-
nary concentrations. Most human biomoni-
toring studies assess atrazine exposure by 
measuring atrazine mercapturate in urine 
samples. This metabolite is formed directly 
from atrazine and cannot result from other 
atrazine degradation processes in the envi-
ronment or organisms (see Barr et al. 2007, 
their Figure 1). However, measurement of 
this metabolite alone misrepresents total 
atrazine exposure (Barr et al. 2007). In our 
study, mothers were considered exposed to 
atrazine when atrazine or at least one of its 
specific metabolites (i.e., formed only from 
atrazine degradation processes: atrazine mer-
capturate, desethylatrazine, hydroxyatrazine, 
or hydroxydesethylatrazine) was quantified 
in their urine. Among them, mothers with 
quantifiable levels of atrazine or atrazine mer-
capturate were classified as “directly exposed” 
to atrazine. We classified mothers as unex-
posed if there was no trace (i.e., < LOQ) of 
atrazine or any of its four specific metabolites 
in their urine sample. We used a similar strat-
egy to classify exposure to simazine and its 
specific metabolites. We also classified women 
as exposed to dealkylated or hydroxylated tri-
azine metabolites if at least one metabolite 
in the respective group was quantified in the 
urine sample, and as exposed to alachlor if 
alachlor or its metabolite 2,6-diethylaniline 
was quantified. Molar concentrations (nano-
moles per liter) were summed to compute 
combined biomarker levels for groups of 
related compounds. For this computation, 
nonquantified values were not imputed (or 
were set at zero), and molar concentrations 
were computed by dividing the chemical 
determination value, expressed in micrograms 
per liter, by the molar mass.
Statistical analyses. Logistic models were 
used to estimate associations between bio-
markers and adverse birth outcomes. We did 
not incorporate case-cohort sampling prob-
abilities because the case-cohort odds ratio 
(OR) approximates the case–control OR 
when the outcome is rare (Kass and Gold 
Table 1. Characteristics of the case-cohort population of pregnant women assessed for urinary biomark-
ers of pesticide exposure (France, 2002–2006).
Subcohort
Major 
congenital 
anomalies FGR SHC Mean ± SE  
(minimum–maximum)Characteristic n (%) n (%) n (%) n (%)
All 579 88 178 103
Year of inclusion
2002–2003 292 (50) 51 (58) 89 (50) 43 (42)
2004 206 (36) 23 (26) 60 (34) 48 (47)
2005–2006 81 (14) 14 (16) 29 (16) 12 (12)
District
Ille-et-Vilaine 361 (62) 63 (72) 112 (63) 58 (56)
Côtes d’Armor 158 (27) 21 (24) 53 (30) 42 (41)
Finistère 35 (6) 3 (3) 8 (4) 1 (1)
Other 25 (4) 1 (1) 5 (3) 2 (2)
Habitat
Rural/semirural area (< 20,000 inhabitants) 473 (82) 72 (82) 151 (85) 92 (89)
Urban (≥ 20,000 inhabitants) 106 (18) 16 (18) 27 (15) 11 (11)
Maternal age (years) 30 ± 0.2 (19–44)
< 25 73 (13) 9 (10) 25 (14) 16 (15)
25–30 224 (39) 30 (34) 60 (34) 38 (37)
30–35 202 (35) 34 (39) 68 (38) 39 (38)
≥ 35 80 (14) 15 (17) 25 (14) 10 (10)
Maternal education
Primary/secondary school 109 (19) 17 (19) 47 (26) 15 (15)
Baccalaureate 109 (19) 16 (18) 28 (16) 24 (23)
Technical school/Postsecondary 360 (62) 55 (63) 103 (58) 64 (62)
Missing 1
Maternal farmwork 8 (1.7) 1 (1.1) 3 (2) 2 (2)
Maternal smoking status at enrollment
Nonsmoker 411 (72) 70 (80) 118 (66) 66 (65)
Nonsmoker but smoked at conception 70 (12) 9 (10) 17 (10) 13 (13)
Smoker 91 (16) 9 (10) 43 (24) 23 (22)
Missing 7 1
Maternal drinking status at enrollment
Abstinent 486 (85) 77 (89) 149 (85) 89 (89)
Occasional (< 1 drink per day) 75 (13) 9 (10) 19 (11) 8 (8)
≥ 1 drink per day 9 (2) 1 (1) 7 (4) 3 (3)
Missing 9 1 3 3
Season of conception
Spring 121 (21) 23 (26) 35 (20) 23 (22)
Summer 162 (28) 15 (17) 48 (27) 34 (33)
Autumn 142 (24) 29 (33) 45 (25) 22 (21)
Winter 154 (27) 21 (24) 50 (28) 24 (23)
Prepregnancy BMI (kg/m2) 22.2 ± 0.2 (15–44)
 < 18.5 51 (9) 10 (11) 12 (7) 11 (11)
18.5–25 426 (74) 68 (77) 133 (75) 77 (75)
25–30 68 (12) 6 (7) 20 (11) 8 (8)
≥ 30 27 (5) 4 (5) 13 (7) 6 (6)
Missing 7 1
Parity
1 264 (46) 43 (49) 83 (47) 57 (55)
2 207 (36) 25 (28) 70 (39) 35 (34)
≥ 3 107 (18) 20 (23) 25 (14) 11 (11)
Missing 1  
Folic acid intake (3 months before inclusion) 100 (17) 7 (8) 22 (12) 16 (16)
High blood pressure before/during pregnancy 32 (6) 2 (2) 26 (15) 4 (4)
Cesarean delivery 100 (17) 14 (16) 42 (24) 10 (10)
Gestational age at inclusion (weeks)a 11.7 ± 0.1 (4–19)
Gestational duration (weeks)a 39.3 ± 0.01 (26–42)
Infant characteristics
Sex
Girls 280 (48) 35 (42) 91 (51) 22 (21)
Boys 299 (52) 48 (58) 87 (49) 81 (79)
Missing 5b
Birth weight (g) 3,376 ± 20 (1,050–4,760)
Birth length (cm) 49.7 ± 0.1 (35–56)
Head circumference at birth (cm) 34.6 ± 0.01 (25–39)
aIn weeks of amenorrhea. bFive medical pregnancy terminations without available data on fetus sex. 
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2004). Covariates considered in multivariate 
analyses were known or suspected risk factors 
and factors that predicted outcomes or urinary 
concentrations in this cohort. An initial list of 
covariates, used for the FGR models, included 
year of enrollment (2002–2003, 2004, 2005–
2006), residence district (Ille-et-Vilaine, Côtes 
d’Armor, Finistère, or other), maternal age 
(< 25, 25–30, 30–35, > 35 years), education 
level (primary/secondary school, baccalaure-
ate, technical school/postgraduate), smoking 
status at enrollment (nonsmoker, nonsmoker 
who smoked at conception, smoker), alco-
hol consumption at enrollment (abstinent, 
occasional, ≥ 1 drink per day), high blood 
pressure before/during pregnancy, season at 
conception, thawing and refreezing process 
(a subset of 52 samples), and urine creatinine 
level (milligrams per liter). For SHC models, 
we also considered cesarean delivery (because 
passage through the birth canal may influ-
ence head circumference at birth), parity (1, 
2, ≥ 3), and prepregnancy body mass index 
(BMI; < 18.5, 18.5–25, 25–30, ≥ 30 kg/m2). 
For congenital anomalies models, in addi-
tion to the initial list, we considered folic acid 
intake during the 3 months before enrollment 
(through vitamin supplementation), mater-
nal fever in early pregnancy (before enroll-
ment), child’s sex, parity, prepregnancy BMI, 
mother’s occupational exposure to solvents 
(no, yes, no job) [in accordance with previ-
ous associations observed from this cohort 
(Garlantézec et al. 2009)], and gestational age 
at birth (in weeks). Linear models were used 
to estimate associations between biomark-
ers and birth weight, birth length, and head 
circumference as continuous outcomes, using 
the same initial list of covariates plus child’s 
sex, parity, prepregnancy BMI, gestational age 
at birth, and squared gestational age, as well 
as fish intake (three categories) and shellfish 
intake (three categories) according to previ-
ous results from this cohort (Guldner et al. 
2007) and, for head circumference, cesarean 
delivery. For all outcomes, the list of covari-
ates also included exposures to herbicides, as 
categorical variables as defined above.
Final models were obtained using a 
backward selection process of the covariates 
(p < 0.20) and forcing in models the exposure 
of interest. Additional analyses considered 
biomarker levels as continuous in models and 
were thus restricted to samples with quantifi-
able levels of the compound of interest. SAS 
software was used for all calculations (SAS/
STAT version 9.1; SAS Institute Inc., Cary, 
NC, USA).
Results
Population. Table 1 describes the case-cohort 
population. We recruited most women in the 
random subcohort in Ille-et-Vilaine during 
2003 and 2004. Brittany’s population density 
is low, and 18% of the women lived in cit-
ies (> 20,000 inhabitants). Average maternal 
age was 30 years, and most were postgrad-
uates. Few (n = 8) were farmers. At enroll-
ment, mean gestational age was 11.7 weeks, 
16% of mothers smoked, and 15% reported 
drinking alcohol occasionally or regularly. 
Prepregnancy BMI was 18.5–25 kg/m2 (nor-
mal range) for 75%. Five percent had high 
blood pressure during pregnancy, and 17% of 
deliveries were by cesarean.
Major congenital anomalies were less fre-
quent for women who conceived during the 
summer [vs. spring: OR = 0.5; 95% confi-
dence interval (CI), 0.2–1.0] and for those 
with periconceptual folic acid supplementa-
tion (OR = 0.4; 95% CI, 0.2–0.9). Risk fac-
tors for FGR were low maternal education 
level (primary/secondary school vs. baccalau-
reate: OR = 1.7; 95% CI, 1.1–2.9), smoking 
(OR = 1.7; 95% CI, 1.1–2.5), or alcohol con-
sumption (≥ 1 drink/day vs. abstinent: OR 
= 2.5; 95% CI, 0.9–6.9) in early pregnancy, 
and high blood pressure during pregnancy 
(OR = 2.9; 95% CI, 1.7–5.1). SHC was less 
common in the babies of women living in cit-
ies (cities vs. rural or semirural/rural areas: OR 
= 0.5; 95% CI, 0.3–1.0), who were multipa-
rous (≥ 3 vs. 1: OR = 0.5; 95% CI, 0.2–0.9), 
or who had cesarean versus vaginal deliveries 
(OR = 0.5; 95% CI, 0.3–1.0), and SHC was 
more common in boys than girls (OR = 3.4; 
95% CI, 2.1–5.7).
Urinary measurements of atrazine and 
other herbicides. The 579 subcohort urine 
samples included only 10 (2%) with quantifi-
able atrazine and 24 (4%) with quantifiable 
atrazine mercapturate (Table 2); the prevalence 
of direct exposure to atrazine (quantification of 
at least one of these two compounds) was 6% 
(32 samples). We observed quantifiable levels 
of simazine or simazine mercapturate in 8% 
of the subcohort. We quantified dealkylated 
triazine metabolites in 20% of subcohort urine 
samples and hydroxylated triazine metabo-
lites in 40%. We observed the highest urinary 
concentrations among the dealkylated triazine 
metabolites. Median and maximum values 
were lowest for the chloroacetanilide com-
pounds and for atrazine mercapturate.
Factors potentially associated with quan-
tification of urinary atrazine or other herbi-
cides. We observed evidence of direct exposure 
to atrazine (i.e., quantification of atrazine or 
atrazine mercapturate) in samples collected 
during all years of the study (Figure 1). The 
proportion of samples with evidence of direct 
exposure did not differ substantially between 
samples from women living in cities and rural 
areas, or according to categories of estimated 
atrazine-contaminated tap water consumption. 
However, it was higher in samples from women 
with the highest fish intake. We observed simi-
lar conclusions for alachlor exposure.
We quantified simazine or simazine mer-
capturate, and dealkylated and hydroxylated 
Table 2. Levels of triazine and chloroacetanilide herbicides quantified in urine from 579 randomly 
selected women from the PELAGIE cohort in early pregnancy (France, 2002–2006).
Herbicide LOQ (μg/L) n (%) > LOQ
Median (95th percentile/maximum) 
among quantified values
Triazine compounds (μg/L)
Atrazine 0.05 10 (2) 0.12 (0.52/0.52)
Atrazine mercapturate 0.02 24 (4) 0.05 (0.49/0.68)
Simazine 0.2 6 (1) 1.0 (4.4/4.4)
Simazine mercapturate 0.06 44 (8) 0.5 (3.4/4.6)
Desethylatrazinea 0.003 60 (10) 0.1 (7.8/14.0)
Desisopropyl atrazinea 0.9 25 (4) 1.4 (7.1/8.2)
2-Chlorodiaminoatrazinea 0.5 42 (7) 1.0 (2.9/5.0)
Hydroxyatrazineb 0.02 57 (10) 0.1 (1.1/4.0)
Hydroxydesethylatrazineb 0.315 31 (5) 0.6 (2.5/2.5)
Hydroxysimazineb 0.02 50 (9) 0.08 (1.1/1.6)
Hydroxy desisopropyl atrazineb 0.15 90 (16) 0.6 (3.5/4.5)
Ammelineb 0.25 79 (14) 0.9 (5.9/7.1)
Chloroacetanilide compounds (μg/L)
Alachlor 0.006 64 (11) 0.03 (0.21/0.65)
2,6-Diethylaniline 0.01 54 (9) 0.03 (0.13/0.82)
Metolachlor 0.002 144 (25) 0.01 (0.18/1.14)
Acetochlor 0.02 51 (9) 0.05 (0.17/1.04)
Creatinine (mg/L) 579 (100) 1,009 (2,014/3,511)
Sum of compounds (nmol/L)c
Σ(atrazine, atrazine mercapturate) 32 (6) 0.2 (1.4/4.4)
Σ(simazine, simazine mercapturate) 47 (8) 2.0 (12.6/21.8)
Σ dealkylated triazine metabolites 117 (20) 5.3 (34.6/74.8)
Σ hydroxylated triazine metabolites 229 (40) 4.4 (30.9/66.5)
Σ(alachlor, 2,6-diethylaniline) 103 (18) 0.2 (1.0/7.2)
aDealkylated triazine metabolites (desethylatrazine, desisopropyl atrazine, 2-chlorodiaminoatrazine). bHydroxylated triaz-
ine metabolites (hydroxyatrazine, hydroxysimazine, hydroxydesethylatrazine, hydroxy desisopropyl atrazine, ammeline). 
cCompounds were summed according to the definition of exposure profiles of interest, as stated in “Materials and 
Methods.” For example, Σ(atrazine, atrazine mercapturate) means that atrazine or atrazine mercapturate was found in 
32 urine samples (sample may contain both compounds) with a median concentration of 0.2 nmol/L.
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triazine metabolites more frequently in 
urine samples of women living in the Côtes 
d’Armor district than in other municipalities, 
in rural areas than in cities, and in munici-
palities with the highest level of atrazine-
 contaminated tap water. The frequency of 
the dealkylated metabolites in urine decreased 
with the proportion of land devoted to corn 
in the mothers’ home municipality (Figure 1).
We quantified chloroacetanilide com-
pounds more frequently in samples from 
women residing in Côtes d’Armor than 
women in other districts. Living in rural areas 
or near corn crops did not appear to explain 
the presence of metolachlor in urine samples, 
but the proportion of samples with evidence 
of metolachlor exposure was higher in sam-
ples from women with the highest intakes of 
fish and seafood (Figure 1).
In addition, our data showed no correla-
tion between concentrations of triazines and 
gestational age at urine collection (4–19 weeks) 
and no relation between the biomarker levels 
and the time (in days) that samples spent at 
ambient temperatures (data not shown), sug-
gesting that it is unlikely that these sources of 
between-subject variation affected our results.
Association between exposure to atrazine 
and other herbicides and adverse pregnancy 
outcomes. Table 3 describes the herbicide 
compounds that co-occurred with atrazine 
exposure in this study. In the 32 urine samples 
from women in the subcohort with evidence 
of direct exposure to atrazine, we also quanti-
fied alachlor, metolachlor, hydroxy atrazine, 
acetochlor, simazine, simazine mercaptur-
ate, and desisopropyl desethylatrazine and 
its hydroxylated form more frequently than 
expected: We found alachlor in 14 samples 
(44% vs. 10% in the subcohort), metolachlor 
in 16 samples (50% vs. 25%), and hydroxy-
atrazine in 10 samples (31% vs. 10%).
Major congenital anomalies were not asso-
ciated with biomarkers of triazine exposure 
but were associated with exposure to simaz-
ine (OR = 1.8; 95% CI, 1.0–3.5; p = 0.07) 
(Table 4). Atrazine exposure (i.e., quantifica-
tion of atrazine or one of its specific metabo-
lites) was associated with FGR (OR = 1.5; 
95% CI, 1.0–2.2) and SHC (OR = 1.7; 95% 
CI, 1.0–2.7). Associations with direct expo-
sure to atrazine were also positive but were 
not statistically significant (Table 4). We 
found no evidence of an association between 
exposure to other triazines and FGR or SHC, 
or between chloroacetanilide herbicides and 
any of the dichotomous pregnancy outcomes.
Birth weight, birth length, and head cir-
cumference were all lower in babies of women 
with atrazine or atrazine mercapturate quanti-
fied in their urine than in babies of women 
not exposed to atrazine; the decrease was sta-
tistically significant for birth weight (–151 g; 
95% CI, –293 to –9 g) (Table 5). Growth 
indicators were positively associated with 
direct exposure to simazine (birth weight: 
130 g; 95% CI, 5–255; length: 0.61 cm; 95% 
CI, 0.1–1.2; head circumference: 0.38 cm; 
95% CI, –0.03 to 0.8) and with alachlor or 
its metabolite in urine (birth weight: 91 g; 
95% CI, 3–179).
Analyses of the babies of the 144 women 
with quantifiable metolachlor indicated a 
significant decrease in head circumference 
(for a 1-nmol/L increase in metolachlor, β = 
–0.53 cm; 95% CI –0.96 to –0.10) and non-
significant decreases in birth weight (–21 g; 
95% CI, –151 to 109) and birth length 
(–0.24 cm; 95% CI, –0.78 to 0.31).
Additional analyses showed a weak posi-
tive association between quantification of 
Figure 1. Possible determinants of triazine and chloroacetanilide herbicide exposure shown by urinary biomarkers in 579 pregnant women randomly selected from 
the PELAGIE cohort (France, 2002-2006). Dealkylated triazine metabolites are desethylatrazine, desisopropyl atrazine, and 2-chlorodiaminoatrazine; hydroxylated 
triazine metabolites are hydroxyatrazine, hydroxysimazine, hydroxydesethylatrazine, hydroxy desisopropyl atrazine, and ammeline.
*Data available only for the Ille-et-Vilaine district. 
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atrazine or one of its specific metabolites in 
urine and male genital anomalies (OR = 1.4; 
95% CI, 0.6–3.2; based on 5 cases classified 
as exposed and 18 as unexposed) and a stron-
ger but nonsignificant association with evi-
dence of direct atrazine exposure (OR = 2.3; 
95% CI, 0.6–8.4; based on 3 cases classified 
as exposed and 18 as unexposed) compared 
with no exposure. Among the 35 mothers 
with quantified atrazine or atrazine mercap-
turate in their urine, the OR for male geni-
tal anomalies associated with a 1-nmol/L 
increase in these compounds was 2.8 (95% 
CI, 0.9–8.6).
Discussion
This study showed the presence of atrazine 
residues in urine samples of pregnant women 
up to 3 years after atrazine was banned in 
Europe. Only a few studies have measured 
urinary levels of triazine compounds in general 
and nonfarm populations (Bakke et al. 2009; 
Curwin et al. 2007), mainly in the United 
States; none focused on pregnant women. 
Curwin et al. (2007) studied 51 nonfarm 
children in Iowa in 2001 and observed higher 
levels of atrazine mercapturate than in our 
study: 12% had detectable levels (and their 
LOD at 1.16 µg/L was higher), and the maxi-
mum level was 2.2 µg/L. Another Iowa study 
of 10 nonfarm men in 2002–2003 observed 
urinary traces of atrazine mercapturate similar 
to our study (6% of detectable levels, with 
an LOD < 0.2 µg/L) (Bakke et al. 2009). As 
Barr et al. (2007) suggested and our results 
confirm, measurement of atrazine mercaptur-
ate alone misrepresents and underestimates 
total atrazine exposure. We measured urinary 
concentrations of other triazine metabolites 
that may also be environmental degradates 
and found higher detection frequencies and 
levels for most of them than for atrazine or 
atrazine mercapturate. That metabolite traces 
are more frequent than the parent substance 
has also been generally observed in environ-
mental media. The detection of atrazine and 
Table 3. Herbicide compounds co-occurring with atrazine exposure in urine samples of 579 pregnant 
women (France, 2002–2006).
No. of urine samples with the co-occurring compound
Co-occurring compound
With no  
exposure to atrazinea
With  
atrazine exposureb
With direct 
atrazine exposurec
Total 425 154 32
Atrazine 0 10 10
Atrazine mercapturate 0 24 24
Desethylatrazine 0 60 3
Hydroxyatrazine 0 57 10
Hydroxydesethylatrazine 0 31 3
Simazine 0 6 2
Simazine mercapturate 20 24 5
Hydroxysimazine 20 30 3
Desisopropyl atrazine 20 5 0
2-Chlorodiaminoatrazine 27 15 5
Hydroxy desisopropyl atrazine 68 22 3
Ammeline 46 33 7
Alachlor 35 29 14
2,6-Diethylaniline 39 15 6
Metolachlor 81 63 16
Acetolachlor 34 17 9
aSamples with no quantified level of atrazine and its four specific metabolites (desethylatrazine, hydroxyatrazine, 
hydroxydesethylatrazine, and atrazine mercapturate). bSamples with at least one quantified compound among atrazine 
or its four specific metabolites. cSamples with a quantified level of atrazine or atrazine mercapturate.
Table 4. Association between pregnancy outcomes and exposure to herbicides assessed from urinary metabolites quantified in maternal samples collected in 
early pregnancy, adjusted for co-occurring exposures to other herbicides (France, 2002–2006).
Herbicide exposure defined by grouping metabolites  
quantified in urine samples
Major congenital anomalies FGR SHC
n ORa (95% CI) n ORb (95% CI) n ORc (95% CI)
Atrazine and its specific metabolitesd
None 62 Reference 117 Reference 65 Reference
At least one 26 1.2 (0.7–2.1) 61 1.5 (1.0–2.2)e 38 1.7 (1.0–2.7)e
At least atrazine or atrazine mercapturate (direct exposure) 6 1.0 (0.3–3.1) 14 1.6 (0.8–3.1) 6 1.3 (0.5–3.3)
Simazine and its specific metabolitesf
None 71 Reference 150 Reference 90 Reference
At least one 17 1.8 (1.0–3.5) 28 1.1 (0.7–1.8) 13 0.8 (0.4–1.7)
At least simazine or simazine mercapturate 9 1.6 (0.7–3.8) 16 1.0 (0.5–1.9) 7 0.6 (0.2–1.6)
Dealkylated triazine metabolitesg
No dealkylated metabolite 74 Reference 140 Reference 84 Reference
At least one 14 0.9 (0.5–1.7) 38 0.9 (0.6–1.5) 19 0.8 (0.4–1.4)
Hydroxylated triazine metabolitesh
No hydroxylated metabolite 48 Reference 107 Reference 58 Reference
At least one 40 1.3 (0.8–2.2) 71 0.8 (0.6–1.3) 45 1.1 (0.7–1.7)
Alachlor
None 71 Reference 144 Reference 84 Reference
At least alachlor or 2,6-diethylaniline 17 0.9 (0.4–1.7) 34 1.3 (0.8–2.0) 19 0.9 (0.5–1.7)
Metolachlor
No 70 Reference 133 Reference 78 Reference
Yes 18 0.8 (0.4–1.4) 45 1.2 (0.8–1.9) 25 1.0 (0.6–1.7)
Acetochlor
No 82 Reference 169 Reference 94 Reference
Yes 6 1.0 (0.4–2.5) 9 0.6 (0.3–1.2) 9 0.8 (0.4–1.6)
Logistic models were adjusted according to backward selection (p < 0.20). The exposure of interest was forced in the model (whatever its p-value). The retained covariates in final 
models are listed in the table notes.
aRetained covariates at p < 0.20: year of enrollment, season at conception, mother’s occupational exposure to solvents, gestational age at birth, and simazine exposure (except for 
the models on dealkylated and hydroxylated metabolites). bRetained covariates at p < 0.20: smoking status at enrollment, high blood pressure before/during pregnancy, thawing and 
refreezing process, acetochlor exposure, and atrazine exposure. cRetained covariates at p < 0.20: residence district, alcohol consumption at enrollment (except for the models on deal-
kylated and hydroxylated metabolites), thawing and refreezing process, cesarean delivery, parity, and atrazine exposure. dDesethylatrazine, hydroxyatrazine, hydroxydesethylatrazine, 
and atrazine mercapturate. eStatistical significance at 5% (the CI does not include 1). fHydroxysimazine and simazine mercapturate. gDealkylated metabolites: desethylatrazine, desiso-
propyl atrazine, and 2-chlorodiaminoatrazine. hHydroxylated metabolites: hydroxyatrazine, hydroxydesethylatrazine, hydroxysimazine, hydroxy desisopropyl atrazine, and ammeline.
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simazine residues in urine samples of preg-
nant women up to 3 years after they were 
banned in Europe in 2003 suggests that these 
pesticides persist several years in the environ-
ment. However, we cannot rule out the pos-
sibility of uses on crops of forbidden products 
that represented 6% of the used products in 
2006 in Brittany (Agreste Bretagne 2009). In 
the present study, we found no evidence of a 
link between herbicide exposure biomarkers 
and area devoted to corn production in the 
mother’s municipality of residence. Although 
our assessment of atrazine contamination in 
tap water was crude and limited to the Ille-
et-Vilaine district and to a period earlier than 
the study period, our descriptive results sug-
gest that water contamination was a likely 
determinant of urinary levels of triazine com-
pounds in our Britton population. Curwin 
et al. (2007) found high correlations between 
the atrazine mercapturate urinary levels of 
members of the same family in nonfarm fami-
lies and suggested possible common sources of 
exposure for them, such as diet or water after 
environmental atrazine contamination.
Our study suggests that environmental 
atrazine exposure may impair fetal growth, as 
shown by outcomes such as FGR and SHC 
that may be considered as pathological enti-
ties. This result was reinforced by inverse 
associations between atrazine exposure and 
the crude fetal growth indicators, especially 
birth weight. To our knowledge, until now 
only limited animal data have suggested 
that gestational atrazine exposure may affect 
fetal growth. Although Rayner et al. (2004) 
showed a decrease in rat pup weight after 
in utero exposure to atrazine alone, the same 
team observed the opposite effect when dams 
were exposed to a low-level mixture of atra-
zine and four degradates (Enoch et al. 2007). 
Little is known about the potential develop-
mental toxicity of either the dealkylated or 
hydroxylated forms of triazine compounds. 
Other studies have suggested that dealkylated 
atrazine metabolites that retain the chlorine 
molecule may be as potent as the parent sub-
stance, whereas hydroxylated metabolites have 
lower potency (Laws et al. 2003; Stoker et al. 
2002). Our study suggests that any adverse 
effect of these dealkylated and hydroxylated 
compounds on fetal growth outcomes would 
likely be driven mainly by metabolites specific 
to atrazine (desethylatrazine, hydroxyatrazine, 
or hydroxydesethylatrazine) and not by other 
dealkylated or hydroxylated triazine metabo-
lites. Finally, our results are consistent with 
those of Munger et al. (1997), Villanueva et al. 
(2005), and Ochoa-Acuña et al. (2009), all of 
whom examined exposure during pregnancy 
to atrazine and its degradates by consumption 
of tap water. We did not, however, confirm 
associations between major congenital anoma-
lies and atrazine exposure suggested in several 
recent ecological studies (Davis 2005; Mattix 
et al. 2007;Waller et al. 2010; Winchester 
et al. 2009). A meta-analysis has already linked 
hypospadias to parental pesticide exposure, 
with possible endocrine-mediated effects 
(Rocheleau et al. 2009). We found only one 
mammal experiment that observed hypospa-
dias in rats treated with atrazine (Wu et al. 
2007). Our finding of an association between 
male genital anomalies and atrazine or atrazine 
mercapturate levels in early-pregnancy urine 
samples was based on small numbers, and it 
requires replication. It would reinforce the 
hypothesis of endocrine-mediated effects of 
low levels of atrazine exposure, formulated 
from animal observations in laboratories and 
in the wild (Hayes et al. 2006).
Our study suggests, for the first time, to 
our knowledge, that simazine exposure and 
alachlor exposure may be positively associ-
ated with fetal growth indicators. However, 
these results need to be replicated. Finally, our 
study suggests that metolachlor exposure lev-
els may be inversely correlated with head cir-
cumference, consistent with the recent report 
by Barr et al. (2010) of an inverse correlation 
Table 5. Association between intrauterine growth indicators and exposure to herbicides assessed from urinary metabolites quantified in maternal samples 
 collected in early pregnancy, adjusted for co-occurring exposures to other herbicides (France, 2002–2006)
Herbicide exposure defined by grouping metabolites 
 quantified in urine samples
Subcohort Birth weight (g) Birth length (cm) Head circumference (cm)
n β-Coefficienta (95% CI) p-Value β-Coefficientb (95% CI) p-Value β-Coefficientc (95% CI) p-Value
Atrazine and its specific metabolitesd
None 425 Reference Reference Reference
At least one 154 –57 (–130 to 17) 0.13 –0.22 (–0.5 to 0.1) 0.20 –0.18 (–0.4 to 0.1) 0.16
At least atrazine or atrazine mercapturate (direct exposure) 32 –151 (–293 to –9) 0.04 –0.44 (–1.1 to 0.2) 0.19 –0.39 (–0.9 to 0.1) 0.10
Simazine and its specific metabolitese
None 506 Reference Reference Reference
At least one 73 40 (–63 to 142) 0.45 0.17 (–0.3 to 0.6) 0.48 0.27 (–0.1 to 0.6) 0.11
At least simazine or simazine mercapturate 47 130 (5 to 255) 0.04 0.61 (0.1 to 1.2) 0.03 0.38 (–0.03 to 0.8) 0.07
Dealkylated triazine metabolitesf
No dealkylated metabolite 462 Reference Reference Reference
At least one 117 –18 (–99 to 62) 0.65 0.03 (–0.3 to 0.4) 0.87 0.18 (–0.1 to 0.4) 0.18
Hydroxylated triazine metabolitesg
No hydroxylated metabolite 350 Reference Reference Reference
At least one 229 –12 (–79 to 55) 0.72 0.002 (–0.3 to 0.3) 0.99 –0.09 (–0.3 to 0.1) 0.41
Alachlor
None 476 Reference Reference Reference
At least alachlor or 2,6–diethylaniline 103 91 (3 to 179) 0.04 0.35 (–0.05 to 0.7) 0.08 0.11 (–0.2 to 0.4) 0.45
Metolachlor
No 435 Reference Reference Reference
Yes 144 5 (–78 to 87) 0.91 –0.20 (–0.6 to 0.1) 0.25 0.04 (–0.2 to 0.3) 0.73
Acetochlor
No 528 Reference Reference Reference
Yes 51 65 (–53 to 183) 0.28 0.13 (–0.4 to 0.7) 0.63 0.09 (–0.3 to 0.5) 0.65
Linear models were adjusted according to backward selection (p < 0.20). The exposure of interest was forced in the model (whatever its p-value). The retained covariates in final mod-
els are listed in the table notes.
aRetained covariates: year of enrollment, education level, smoking status at enrollment, high blood pressure before/during pregnancy, thawing and refreezing process, prepregnancy 
BMI, child’s sex, shellfish intake (except for the models on dealkylated and hydroxylated metabolites), gestational age at birth, squared gestational age, alachlor exposure, and atrazine 
exposure. bRetained covariates: year of enrollment, smoking status at enrollment, high blood pressure before/during pregnancy, season at conception, prepregnancy BMI, child’s sex, 
shellfish intake, gestational age at birth, squared gestational age, alachlor exposure, and atrazine exposure (except for the models on dealkylated and hydroxylated metabolites and on 
metolachlor). cRetained covariates: residence district, smoking status at enrollment, prepregnancy BMI, child’s sex, cesarean delivery, parity, shellfish intake, gestational age at birth, 
squared gestational age, atrazine exposure, and simazine exposure. dDesethylatrazine, hydroxyatrazine, hydroxydesethylatrazine, and atrazine mercapturate. eHydroxysimazine and 
simazine mercapturate. fDealkylated metabolites: desethylatrazine, desisopropyl atrazine, and 2-chlorodiaminoatrazine. gHydroxylated metabolites: hydroxyatrazine, hydroxydesethyla-
trazine, hydroxysimazine, hydroxy desisopropyl atrazine, and ammeline. 
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with birth weight. In the present study, we 
took into account coexposures to herbicides 
as potential confounding factors in all models.
Because cohort members were asked to 
provide only one urine sample for this study, 
possible intraindividual variability cannot be 
considered. We assumed that one sample was 
enough to reflect chronic exposure result-
ing from environmental atrazine contamina-
tion. Chemical stability analyses suggest that 
our study may have nondifferentially under-
estimated atrazine exposure levels, because of 
routine post shipment of urine samples.
Conclusion
This is the first study to assess the association 
between urinary biomarkers of exposure to tri-
azine compounds during pregnancy and adverse 
birth outcomes and to take into account expo-
sure to mixtures of atrazine, its environmental 
degradates, and other co-occurring herbicides. 
Because atrazine is banned in Europe, this study 
deals with environmental contamination by 
atrazine and its persistence in environment, 
which leads to low levels of atrazine exposure. 
Our results thus raise particular concerns for 
countries where atrazine is still in use.
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